ClinicalTrials.gov
public full text
Public Domain
Real-World Treatment of ADC-Resistant HER2-Low Advanced Breast Cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Related documents
- HER2-positive Breast Cancer Project Initiated by Investigators#1009213
- Factors influencing oncologists’ decisions for germline BRCA testing and adjuvant therapy selection in HER2-negative early breast cancer.#988621
- HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC#806649
- HER2 Expression of CTC to Predict Response in HER2-positive Advanced Breast Cancer Patients Treated With ADC#838847
- Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer#1112626
Record · ID 366617 · SHA-256 66ba04e716eacfbd
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive